2024-05-15T12:15:45-05:00 2023-06-30 390859910 BAKER TILLY US LLP 1570 FRUITVILLE PIKE SUITE 400 LANCASTER PA 17601 990 2022-07-01 210672684 CORIELL INSTITUTE FOR MEDICAL RESEARCH INC CORI 8567574828 403 HADDON AVENUE CAMDEN NJ 08103 DENISE L BUSCHER CFO 8567574828 2024-05-14 1 DENISE BUSCHER 999009999 0 X KERRI N BOGDA CPA P00760402 7177404863 2024-05-08 2 AAL1 IAL1 2022 2023-04-26 12:10:37Z DR JEAN-PIERRE ISSA 403 HADDON AVENUE CAMDEN NJ 08103 23930016 0 X WWW.CORIELL.ORG X 1953 NJ GENERATE WORLD CLASS BIOMATERIALS AND CONDUCT GROUNDBREAKING RESEARCH. 17 16 126 16 0 0 3217491 2510168 19900725 20786182 84691 104954 77704 11087 23280611 23412391 0 0 0 0 9568552 11030292 0 0 89683 10744099 11266445 20312651 22296737 2967960 1115654 27584123 29676741 5957255 6863084 21626868 22813657 CORIELL'S MISSION IS TO ACCELERATE SCIENTIFIC DISCOVERY BY GENERATING, BANKING, STORING AND DISTRIBUTING WORLD-CLASS BIOMATERIALS, AND CONDUCTING GROUNDBREAKING RESEARCH IN GENETICS AND EPIGENETICS. 0 0 16810424 0 20786182 THE CORIELL INSTITUTE FOR MEDICAL RESEARCH IS A GLOBALLY RECOGNIZED LEADER IN BIOBANKING AND BIOMEDICAL RESEARCH. CORIELL IS HOME TO ONE OF THE WORLD'S MOST IMPORTANT BIOBANKS WHICH DISTRIBUTES BIOLOGICAL SAMPLES AND OFFERS RESEARCH AND BIOBANKING SERVICES TO SCIENTISTS AROUND THE WORLD. CORIELL IS THE TRUSTED STEWARD OF WORLD-RENOWNED COLLECTIONS FOR THE NATIONAL INSTITUTES OF HEALTH, DISEASE FOUNDATIONS AND COMMERCIAL CLIENTS. IN ADDITION, AS A LEADER IN GENOMIC AND EPIGENOMIC RESEARCH, CORIELL IS UNCOVERING WAYS OR GENETIC MAKEUP AFFECTS OUR HEALTH, ESPECIALLY IN REGARD TO CANCER AND AGING. 16810424 1 1 0 1 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 38 0 126 1 0 0 0 0 0 0 0 0 0 0 0 0 X 17 16 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 1 1 NJ PA NY CA X HEATHER WHITE CONTROLLER 8567579738 403 HADDON AVENUE CAMDEN NJ 08103 DR JEAN-PIERRE ISSA PRESIDENT/CEO 40.00 X X 663507 0 38363 ROBERT KIEP III CHAIR 1.00 X X 0 0 0 MARC MASER ESQ VICE CHAIR 1.00 X X 0 0 0 ARNAUD BASTIEN MD TRUSTEE 1.00 X 0 0 0 PETER DRISCOLL ESQ TRUSTEE 1.00 X 0 0 0 CHRISTOPHER GIBSON TRUSTEE 1.00 X 0 0 0 FRANK GIORDANO TRUSTEE 1.00 X 0 0 0 GENEROSA GRANA TRUSTEE 1.00 X 0 0 0 MATTHEW HEWITT TRUSTEE 1.00 X 0 0 0 GEORGE NORCROSS TRUSTEE 1.00 X 0 0 0 JOHN PICCONE TRUSTEE 1.00 X 0 0 0 ANNETTE REBOLI TRUSTEE 1.00 X 0 0 0 KENNETH SOMBERG TRUSTEE 1.00 X 0 0 0 ROLAND SCHWARTING TRUSTEE 1.00 X 0 0 0 ANTONIO TILLIS TRUSTEE 1.00 X 0 0 0 EDWARD VINER MD TRUSTEE 1.00 X 0 0 0 MIRUNA SASU TRUSTEE 1.00 X 0 0 0 DANA REDD TRUSTEE (UNTIL 12/22) 1.00 X 0 0 0 CONSTANTINE DEAN STOIOS CHIEF FINANCIAL OFFICER/TREASURER 40.00 X 267037 0 35087 NAHID TURAN CHIEF BIOBANKING OFFICER 40.00 X 192635 0 32028 JAROLAV JELINEK CHIEF SCIENTIFIC OFFICER 40.00 X 189939 0 22126 LEO JOSE CHIEF INFORMATION OFFICER 40.00 X 204614 0 16035 COURTNEY DIRKS SR DIRECTOR, PUBLIC RELATIONS 40.00 X 170577 0 32953 DENISE BUSCHER CONTROLLER 40.00 X 147961 0 12779 ARTHUR TELEFEIAN DIR., SALES 40.00 X 136397 0 28247 RYAN CUNNINGHAM ASSOCIATE DIRECTOR 40.00 X 134498 0 24641 RUTHSABEL O'LEXY DIR., RESEARCH OFFICE 40.00 X 134055 0 10635 2241220 0 252894 23 0 1 0 VAN ANDEL INSTITUTE 333 BOSTWICK AVENUE NE GRAND RAPIDS MI 49503 NCI P50 SUBAWARD - RESEARCH/LAB WORK 427500 JOHNS HOPKINS UNIVERSITY 3400 N CHARLES STREET BALTIMORE MD 21218 NCI P50 SUBAWARD - RESEARCH/LAB WORK 285567 UNIVERSITY OF FLORIDA 307 GRINTER HALL PO BOX 115500 GAINESVILLE FL 32611 NIH R01 SUBAWARD - RESEARCH/LAB WORK 245604 UNIVERSITY OF MD BALTIMORE 620 W LEXINGTON STREET BALTIMORE MD 21201 NCI P50 SUBAWARD - RESEARCH/LAB WORK 244016 HACKENSACK MERIDIAN HEALTH 343 THORNALL STREET EDISON NJ 08854 NCI P50 SUBAWARD - RESEARCH/LAB WORK 146939 11 547 2000000 509621 2510168 GOVT FEES & CONTRACTS 621500 17605087 17605087 NON-GOVERNMENT REPOSITORY SERVICE 621500 3109818 3109818 INVESTIGATOR DIRECTED SCIENCE 621500 71277 71277 20786182 92716 92716 529863 517625 12238 12238 12238 MISCELLANEOUS INCOME 900099 11087 11087 11087 23412391 20786182 0 116041 X 1659995 1659995 6707074 5869679 837395 474136 398829 75307 1590538 1500831 89707 598549 441470 157079 120068 120068 151164 151164 67400 67400 2931779 2306109 535987 89683 639338 615201 24137 4027489 2806898 1220591 220521 59776 160745 1249695 953632 296063 LAB SUPPLIES 1858698 1857706 992 GENOTYPING SUPPLIES 293 293 22296737 16810424 5396630 89683 1200 1200 1280831 202792 4003360 3045757 762814 1785356 98066 120095 330690 314083 37403184 27804497 6207343 9598687 3387809 3197156 300000 300000 11212010 11111615 27584123 29676741 1168678 2138788 102518 38237 4675500 4675500 10559 10559 5957255 6863084 X 12768886 14191772 8857982 8621885 21626868 22813657 27584123 29676741 X 1115654 204393 -133258 X 0 1 X 1 0 X 1275612 1005217 1087567 3217491 2510168 9096055 1275612 1005217 1087567 3217491 2510168 9096055 272800 8823255 84624 67021 62800 83936 92716 391097 20102 918 532774 77704 11087 642585 10129737 86023258 0.87100 0.79510 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: MISCELLANEOUS INCOME - 2019 AMOUNT: $ 918. 2020 AMOUNT: $ 532,774. 2021 AMOUNT: $ 77,704. 2022 AMOUNT: $ 11,087. LIFE INSURANCE PROCEEDS - 2018 AMOUNT: $ 20,102. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 67400 67400 22229337 22296737 1000000 250000 0 0 1000000 1000000 1000000 1000000 4000000 6000000 63384 66438 67900 67400 265122 250000 250000 250000 250000 1000000 1500000 3387810 309347 500000 3197157 3188112 350000 -150302 3387810 1837972 855673 494467 3188112 2002448 3148 -167624 1837972 3291341 61107 1350000 2002448 0.30000 0.26000 0.44000 0 0 245000 245000 18918711 13061878 5856833 1725594 1634213 91381 16513879 13108406 3405473 9598687 NEW JERSEY CORD BLOOD BANK 4675500 USE OF RESEARCH FACILITY 5877977 SPLIT-INTEREST AGREEMENTS 490170 OTHER MISCELLANEOUS ASSETS 4185 OVER RECOVERY INDIRECT COSTS 30920 PREPAID CAPITAL CONTRIBUTIONS 32863 11111615 ADVANCES ON HAND 10127 HOLDING ACCOUNTS 432 10559 X 24135801 204393 652275 -133258 723410 23412391 0 23412391 22949012 652275 652275 22296737 0 22296737 PART V, LINE 4: THE INSTITUTE'S ENDOWMENT FUNDS ARE USED TO SUPPORT THE SHORT AND LONG TERM GOALS OF THE INSTITUTE. THE INSTITUTE DREW $500,000 OF FUNDS FROM THE ENDOWMENT DURING THE YEAR ENDING JUNE 30, 2023. PART X, LINE 2: THE INSTITUTE ACCOUNTS FOR UNCERTAINTY IN INCOME TAXES USING A RECOGNITION THRESHOLD OF MORE LIKELY THAN NOT TO BE SUSTAINED UPON EXAMINATION BY THE APPROPRIATE TAXING AUTHORITY. MEASUREMENT OF THE TAX UNCERTAINTY OCCURS IF THE RECOGNITION THRESHOLD HAS BEEN MET. MANAGEMENT DETERMINED THAT THERE WERE NO TAX UNCERTAINTIES THAT MET THE RECOGNITION THRESHOLD IN 2023 AND 2022. X X 1 1 X X X X 0 0 0 0 0 0 0 1 0 DR JEAN-PIERRE ISSA PRESIDENT/CEO 526443 0 135000 0 2064 0 21350 0 17013 0 701870 0 0 0 CONSTANTINE DEAN STOIOS CHIEF FINANCIAL OFFICER/TREASURER 258933 0 7000 0 1104 0 18926 0 16161 0 302124 0 0 0 NAHID TURAN CHIEF BIOBANKING OFFICER 184483 0 7551 0 601 0 13430 0 18598 0 224663 0 0 0 LEO JOSE CHIEF INFORMATION OFFICER 201986 0 1000 0 1628 0 14236 0 1799 0 220649 0 0 0 JAROLAV JELINEK CHIEF SCIENTIFIC OFFICER 182591 0 4000 0 3348 0 13064 0 9062 0 212065 0 0 0 COURTNEY DIRKS SR DIRECTOR, PUBLIC RELATIONS 157177 0 13056 0 344 0 11811 0 21142 0 203530 0 0 0 ARTHUR TELEFEIAN DIR., SALES 134607 0 583 0 1207 0 9947 0 18300 0 164644 0 0 0 DENISE BUSCHER CONTROLLER 145019 0 2235 0 707 0 10085 0 2694 0 160740 0 0 0 RYAN CUNNINGHAM ASSOCIATE DIRECTOR 133228 0 1055 0 215 0 9607 0 15034 0 159139 0 0 0 PART I, LINE 1A RYAN CUNNINGHAM, RUTHSABEL O'LEXY AND COURTNEY DIRKS RECEIVED TAX GROSS-UP PAYMENTS RELATED TO SERVICE AWARDS AND BONUSES RECEIVED. ALL AMOUNTS ARE INCLUDED AS TAXABLE COMPENSATION. JAROSLAV JELINEK AND NAHID TURAN HAVE DISCRETIONARY SPENDING ACCOUNTS TO BE UTILIZED FOR BUSINESS PURPOSES ONLY AND FOLLOWING ALL NORMAL PURCHASING/TRAVEL POLICIES OF THE ORGANIZATION. THESE ACCOUNTS CANNOT BE USED FOR PERSONAL EXPENSES. PART I, LINE 7 THE COMPENSATION COMMITTEE DETERMINES BONUSES FOR OFFICERS AND KEY EMPLOYEES BASED UPON VARIOUS PERFORMANCE CRITERIA. PERFORMANCE CRITERIA ARE BASED ON VARIOUS OBJECTIVES, SOME OF WHICH ARE BASED ON BUSINESS/ FINANCIAL GOALS. OVERALL, THE PRIMARY OBJECTIVES ARE OPERATIONAL IN NATURE WITH CONSIDERATION GIVEN TO FINANCIAL OUTCOMES. FORM 990, PART VI, SECTION A, LINE 1A THERE ARE 9 BOARD MEMBERS ON THE EXECUTIVE COMMITTEE. WITH THE EXCEPTION OF THE PRESIDENT AND CEO, THE OTHER BOARD MEMBERS OF THE EXECUTIVE COMMITTEE ARE NON-EMPLOYED VOLUNTARY BOARD MEMBERS. THE EXECUTIVE COMMITTEE MAY ACT ON BEHALF OF THE BOARD OF TRUSTEES WHEN THE BOARD IS NOT IN SESSION. FORM 990, PART VI, SECTION B, LINE 11B THE CFO PERFORMS AN INITIAL REVIEW OF THE FORM 990. AFTER INTERNAL REVIEW, THE CFO WILL PROVIDE THE DRAFT FORM 990 TO THE AUDIT COMMITTEE. FOLLOWING THE REVIEW BY THE AUDIT COMMITTEE THE FORM IS DISTRIBUTED TO ALL CORIELL TRUSTEES BEFORE FILING WITH THE IRS. FORM 990, PART VI, SECTION B, LINE 12C THE CEO ANNUALLY DISTRIBUTES THE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH MEMBER OF THE BOARD OF TRUSTEES. EACH TRUSTEE MUST COMPLETE AND RETURN THE ANNUAL DISCLOSURE STATEMENT TO THE CEO ON A TIMELY BASIS. HE OR SHE MUST TIMELY INFORM THE CEO AND/OR THE COMMITTEE OF ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST OR OF ANY SITUATION WHICH MIGHT LEAD TO THE APPEARANCE OF A CONFLICT OF INTEREST. IN ADDITION, THE CHIEF FINANCIAL OFFICER (CFO) ANNUALLY DISTRIBUTES A COPY OF THE EMPLOYEE CONFLICT OF INTEREST POLICY AND DISCLOSURE STATEMENT TO EACH OFFICER, EXECUTIVE, AND APPROPRIATE EMPLOYEE. THESE EMPLOYEES ARE REQUIRED TO SUBMIT THE COMPLETED DISCLOSURE STATEMENT TO THE CFO AND DISCLOSE ANY POTENTIAL OR ACTUAL CONFLICT OF INTEREST. REPORTED CONFLICTS OF INTEREST ARE SHARED WITH THE EXECUTIVE COMMITTEE. ANY BOARD MEMBER WHO HAS A CONFLICT OF INTEREST IS EXCLUDED FROM VOTING ON ANY ISSUE INVOLVING THE CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 USING COMPARABILITY DATA SOURCED FROM AN INDEPENDENT ORGANIZATION, A BOARD OF TRUSTEES' COMPENSATION COMMITTEE REVIEWS THE PERFORMANCE AND ESTABLISHES THE ANNUAL COMPENSATION FOR THE CHIEF EXECUTIVE OFFICER. COMPENSATION DECISIONS ARE DETERMINED BY TAKING INTO CONSIDERATION THE FAIR MARKET RANGE FOR THE INDUSTRY. ALL COMMITTEE DISCUSSIONS ARE DOCUMENTED IN BOARD MINUTES. THE PRESIDENT DETERMINES THE COMPENSATION ANNUALLY FOR ALL OTHER EMPLOYEES, INCLUDING OFFICERS AND KEY EMPLOYEES, BASED ON PERFORMANCE APPRAISALS AND REVIEWS. FORM 990, PART VI, SECTION C, LINE 19 THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. FORM 990, PART IX, LINE 11G PROFESSIONAL SERVICES: PROGRAM SERVICE EXPENSES 2,244,242. MANAGEMENT AND GENERAL EXPENSES 324,090. FUNDRAISING EXPENSES 89,683. TOTAL EXPENSES 2,658,015. ADMINISTRATIVE COSTS: PROGRAM SERVICE EXPENSES 61,867. MANAGEMENT AND GENERAL EXPENSES 211,897. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 273,764. FORM 990, PART XI, LINE 9: CHANGE IN VALUE OF SPLIT-INTEREST AGREEMENTS 21,330. CHANGE IN VALUE OF FUTURE BUILDING OCCUPANCY -154,588. CORIELL LIFE SCIENCES 403 HADDON AVENUE CAMDEN NJ 08103 461794812 GENETIC DATA STORAGE AND INTERPRETATION DE N/A C -999671 517255 0.39880 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 0 1 0 0